United Kingdom (UK) Fibromyalgia Syndrome Market (2025-2031) | Size & Revenue, Growth, Trends, Value, Industry, Companies, Forecast, Share, Outlook, Analysis, Competitive Landscape, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Fibromyalgia Syndrome Market - Industry Life Cycle

3.4 United Kingdom (UK) Fibromyalgia Syndrome Market - Porter's Five Forces

3.5 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis rates of fibromyalgia syndrome in the UK

4.2.2 Growing research and development activities focused on fibromyalgia treatments

4.2.3 Rising healthcare expenditure and government initiatives supporting chronic pain management

4.3 Market Restraints

4.3.1 Lack of effective treatment options for fibromyalgia syndrome

4.3.2 High cost associated with existing treatment options and therapies

4.3.3 Limited understanding of the underlying causes of fibromyalgia syndrome

6.1 United Kingdom (UK) Fibromyalgia Syndrome Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.4 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Anticonvulsants, 2021- 2031F

6.1.5 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Muscle Relaxants, 2021- 2031F

6.1.6 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Analgesics, 2021- 2031F

6.2 United Kingdom (UK) Fibromyalgia Syndrome Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F

6.2.3 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Drug Stores, 2021- 2031F

6.2.4 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.2.5 United Kingdom (UK) Fibromyalgia Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7.1 United Kingdom (UK) Fibromyalgia Syndrome Market Export to Major Countries

7.2 United Kingdom (UK) Fibromyalgia Syndrome Market Imports from Major Countries

8.1 Average time to diagnosis for fibromyalgia patients in the UK

8.2 Number of clinical trials investigating new treatments for fibromyalgia in the UK

8.3 Patient-reported outcomes related to pain management and quality of life for fibromyalgia patients in the UK

9.1 United Kingdom (UK) Fibromyalgia Syndrome Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Kingdom (UK) Fibromyalgia Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United Kingdom (UK) Fibromyalgia Syndrome Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Fibromyalgia Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters